Montreal, Canada

Carmen Leung


Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Quebec, CA (2008)
  • Montreal, CA (2011)

Company Filing History:


Years Active: 2008-2011

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Pain Management: The Inventions of Carmen Leung

Introduction

Carmen Leung is an influential inventor based in Montreal, Canada, recognized for her significant contributions to pharmaceutical innovations. With two patents to her name, she focuses on developing compounds that have therapeutic applications, particularly in pain management.

Latest Patents

Carmen's latest patents include innovative compounds of formula I, specifically benzodiazepine derivatives. These compounds are not only novel peroforms but have potential implications for the management of pain. The patents detail the preparation of these compounds, including their salts and enantiomers, along with pharmaceutical compositions that incorporate them. This groundbreaking work highlights her dedication to advancing medical therapies.

Career Highlights

Currently, Carmen Leung is associated with AstraZeneca AB, where she collaborates on various research projects aimed at enhancing drug efficacy and safety. Her extensive research has led to the development of compounds that promise significant advancements in therapeutic treatments.

Collaborations

Throughout her career, Carmen has worked alongside notable colleagues, including Miroslaw Jerzy Tomaszewski and Simon Woo. Their combined efforts in research and development further emphasize the importance of teamwork in achieving innovative breakthroughs in pharmaceuticals.

Conclusion

Carmen Leung's inventive spirit and dedication to improving therapeutic options make her a remarkable figure within the pharmaceutical industry. Her contributions not only reflect her expertise but also highlight the vital role of women inventors in the field of science and technology. As she continues her work at AstraZeneca AB, the medical community eagerly anticipates the impact of her future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…